Our findings suggest that elevated IRAK1BP1 is associated with suppressed oncogenic signatures in both lung cancer cell lines and patient data, further showing promise for IRAK1BP1 as a predictor of lung cancer prognosis. Here, IRAK1BP1 is linked to lung carcinoma.